517 filings
ARS
2023 FY
BBIO
BridgeBio Pharma Inc
25 Apr 24
Annual report to shareholders
4:07pm
DEFA14A
BBIO
BridgeBio Pharma Inc
25 Apr 24
Additional proxy soliciting materials
4:05pm
DEF 14A
BBIO
BridgeBio Pharma Inc
Definitive proxy
25 Apr 24
4:01pm
4
BBIO
BridgeBio Pharma Inc
14 Mar 24
BridgeBio Pharma / Neil Kumar ownership change
4:00pm
4
Brian C Stephenson
14 Mar 24
BridgeBio Pharma / BRIAN C STEPHENSON ownership change
4:00pm
424B5
3fj5iabh55 rjx
6 Mar 24
Prospectus supplement for primary offering
5:15pm
8-K
uulpcvm4b
6 Mar 24
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
5:13pm
4
budcj9ii ud8w
5 Mar 24
BridgeBio Pharma / Randal W. Scott ownership change
4:00pm
424B5
yjf3u7v 8dtk4o090tbq
4 Mar 24
Prospectus supplement for primary offering
5:25pm
8-K
yw4uyjciecg4tbw5
4 Mar 24
Entry into a Material Definitive Agreement
7:00am
8-K
igh321o4ly ixska
22 Feb 24
BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
7:31am
4
3nq9m cznbfqeblcgtz
21 Feb 24
BridgeBio Pharma / BRIAN C STEPHENSON ownership change
4:04pm
4
q702ui77 zmptl
21 Feb 24
BridgeBio Pharma / CHARLES J HOMCY ownership change
4:04pm
4
a8pd4z9
21 Feb 24
BridgeBio Pharma / Neil Kumar ownership change
4:03pm
4
8a00zw
20 Feb 24
BridgeBio Pharma / Hannah Valantine ownership change
4:03pm
SC 13G/A
ecy5ysno13
16 Feb 24
BridgeBio Pharma / Kumar Neil ownership change
7:15pm
144
6ohluhlr7n8so
15 Feb 24
Notice of proposed sale of securities
4:06pm
SC 13G/A
w1ujyiu jv8d
13 Feb 24
BridgeBio Pharma / VANGUARD ownership change
5:00pm
5
8txuhcqzh3 zlod8
13 Feb 24
BridgeBio Pharma / Hannah Valantine ownership change
4:05pm